Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release

Biomaterials

Volumn 21, Issue 1, 2000, Pages 9-21

  Mowery, Kelly A ^a   H Schoenfisch, Mark ^a   Saavedra, Joseph E ^b   Keefer, Larry K ^c   Meyerhoff, Mark E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biomaterial surfaces; Blood compatibility; Nitric oxide; Polymer materials

Indexed keywords

DIAZENIUMDIOLATE DERIVATIVE; HEPARIN; NITRIC OXIDE DONOR; POLYMER; POLYURETHAN; POLYVINYLCHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BLOOD COMPATIBILITY; CHEMICAL INTERACTION; COVALENT BOND; DRUG RELEASE; PRIORITY JOURNAL; REACTION ANALYSIS; SYNTHESIS; THROMBOCYTE ADHESION;

ANIMALS; BIOCOMPATIBLE MATERIALS; KINETICS; MEMBRANES, ARTIFICIAL; NITRIC OXIDE; NITRIC OXIDE DONORS; PLATELET ADHESIVENESS; POLYURETHANES; POLYVINYL CHLORIDE; SHEEP; SURFACE PROPERTIES; THROMBOSIS;

EID: 0033991479     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(99)00127-1     Document Type: Article

References (58)

1. Banerjee R., Nageswari K., Puniyani R.R. Hematological aspects of biocompatibility. J Biomat Appl. 12:1997;57-76.
2. Suh H. Recent advances in biomaterials. Yonsei Med J. 39:1998;87-96.
3. Benmakroha Y., Zhang S., Rolfe P. Haemocompatibility of invasive sensors. Med Biol Eng Comput. 33:1995;811-821.
4. Lane D.A., Bowry S.K. The scientific basis for selection of measures of thrombogenicity. Nephrol Dial Transplant. 9(Suppl. 2):1993;18-28.
5. Anderson J.M., Kottke-Marchant K. Platelet interactions with biomaterials and artificial devices. CRC Crit Rev Biocompat. 1:1985;111-204.
6. Espadas-Torre C., Meyerhoff M.E. Thrombogenic properties of untreated and poly(ethylene oxide)-modified polymeric matrices useful for preparing intraarterial ion-selective electrodes. Anal Chem. 67:1995;3108-3114.
7. Chen J.H., Wei J., Chang C.Y., Laiw R.F., Lee Y.D. Studies on segmented polyetherurethane for biomedical application. effects of composition and hard-segment content on biocompatibility J Biomed Mat Res. 41:1998;633-648.
8. Kyrolainen M, Rigsby P, Eddy S, Vadgama P. Bio/haemocompatibility: implications and outcomes for sensors? Acta Anaesthesiol Scand 1995;39(Suppl 104):55-60.
9. Yoda R. Elastomers for biomedical applications. J Biomater Sci Polym Ed. 9:1998;561-626.
10. Weerwind P.W., van der Veen F.H., Lindhout T., de Jong D.S., Calahan F.T. Ex vivo testing of heparin-coated extracorporeal circuits. bovine experiments Int J Artif Organs. 21:1998;291-298.
11. Walpoth B.H., Rogulenko R., Tikhvinskaia E., Gogolewski S., Schaffner T., Hess O.M., Althaus U. Improvement of patency rate in heparin-coated small synthetic vascular grafts. Circulation. 98:1998;II319-II323.
12. Pasic M., MullerGlauser W., vonSegesser L., Odermatt B., Lachat M., Turina M. Endothelial cell seeding improves patency of synthetic vascular grafts. manual versus automatized method Eur J Cardio-Thorac Surg. 10:1996;372-379.
13. Marois Y., Chakfe N., Guidoin R., Duhamel R.C., Roy R., Marois M., King M.W., Douville Y. An albumin-coated polyester arterial graft. in vivo assessment of biocompatibility and healing characteristics Biomaterials. 17:1996;3-14.
14. Ratner B.D. Molecular design strategies for biomaterials that heal. Macromol Symposia. 130:1998;327-335.
15. Siney L., Lewis M.J. Endothelium-derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium. Eur J Pharmacol. 229:1992;223-226.
16. Salvemini D., Radziszewski W., Korbut R., Vane J. The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors. Br J Pharmacol. 101:1990;991-995.
17. Radomski M.W., Rees D.D., Dutra A., Moncada S. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol. 107:1992;745-749.
18. Radomski M.W., Palmer R.M.J., Moncada S. The anti-aggregating properties of vascular endothelium. interactions between prostacyclin and nitric oxide Br J Pharmacol. 92:1987;639-646.
19. Meyerhoff M.E. In vivo blood-gas and electrolyte sensors. progress and challenges Trends Anal Chem. 12:1993;257-266.
20. Kelm M., Yoshida K. Metabolic fate of nitric oxide and related N-oxides. Feelisch M., Stamler J.S. Methods in nitric oxide research. 1996;47-58 Wiley, Chichester.
21. Hanson S.R., Hutsell T.C., Keefer L.K., Mooradian D.L., Smith D.J. Nitric oxide donors. a continuing opportunity in drug design Adv Pharmacol. 34:1995;383-398.
22. - group. J Med Chem. 39:1996;1148-1156.
23. Espadas-Torre C., Oklejas V., Mowery K., Meyerhoff M.E. Thromboresistant chemical sensors using combined nitric oxide release/ion sensing polymeric films. J Am Chem Soc. 119:1997;2321-2322.
24. Hrabie J.A., Klose J.R., Wink D.A., Keefer L.K. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem. 58:1993;1472-1476.
25. Mowery KA, Schoenfisch MH, Baliga N, Wahr JA, Meyerhoff ME. More biocompatible electrochemical sensors using nitric oxide release polymers. Electroanalysis 1999, in press.
26. Saavedra JE, Booth MN, Hrabie JA, Davies KM, Keefer LK. Piperazine as a linker for incorporating the nitric oxide-releasing diazeniumdiolate group into other biomedically relevant functional molecules. J Org Chem 1999, in press.
27. Hrabie J.A., Saavedra J.E., Davies K.M., Keefer L.K. Adducts of piperazine with nitric oxide. Org Prep Proced Int. 31:1999;189-192.
28. Ignarro L.J., Fukuto J.M., Griscavage J.M., Rogers N.E. Byrns RE. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate. comparison with enzymatically formed nitric oxide from L-arginine Proc Natl Acad Sci USA. 90:1993;8103-8107.
29. Schmidt H.H.H.W., Kelm M. Determination of nitrite and nitrate by the Griess reaction. Feelisch M., Stamler J.S. Methods in nitric oxide research. 1996;491-497 Wiley, Chichester.
30. Hulanicki A., Matuszewski W., Trojanowicz M. Flow-injection determination of nitrite and nitrate with biamperometric detection at two platinum wire electrodes. Anal Chim Acta. 194:1987;119-127.
31. Sabri M.I., Soiefer A.I., Kisby G.E., Spencer P.S. Determination of polyamines by precolumn derivatization with 9-fluorenylmethyl chloroformate and reverse-phase high-performance liquid chromatography. J Neurosci Methods. 29:1989;27-31.
32. Stead D.A., Richards R.M.E. Sensitive fluorimetric determination of gentamicin sulfate in biological matrices using solid-phase extraction, pre-column derivatization with 9-fluorenylmethyl chloroformate and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Appl. 675:1996;295-302.
33. Davson H. Some equations used in permeability studies. Davson H., Danielli J.F. Permeability of natural membranes. 1952;38-47 Cambridge University Press, London.
34. Yun J.H., Ma S., Fu B., Yang V.C., Meyerhoff M.E. Direct potentiometric membrane electrode measurements of heparin binding to macromolecules. Electroanalysis. 5:1993;719-724.
35. Fu B., Bakker E., Yun J.H., Yang V.C., Meyerhoff M.E. Response mechanism of polymer membrane-based potentiometric polyion sensors. Anal Chem. 66:1994;2250-2259.
36. Ramamurthy N., Baliga N., Wahr J.A., Schaller U., Yang V.C., Meyerhoff M.E. Improved protamine-sensitive membrane electrode for monitoring heparin concentrations in whole blood via protamine titration. Clin Chem. 44:1998;606-613.
37. Keefer L.K., Nims R.W., Davies K.M., Wink D.A. 'NONOates' (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors. convenient nitric oxide dosage forms Methods Enzymol. 268:1996;281-293.
38. Merchant K., Chen H., Gonzalez T.C., Keefer L.K., Shaw B.R. Deamination of single-stranded DNA cytosine residues in aerobic nitric oxide solution at micromolar total NO exposures. Chem Res Toxicol. 9:1996;891-896.
39. Miwa M., Stuehr D.J., Marletta M.A., Wishnok J.S., Tannenbaum S.R. Nitrosation of amines by stimulated macrophages. Carcinogenesis. 8:1987;955-958.
40. Loeppky R.N. Nitrosamine and N-nitroso compound chemistry and biochemistry. advances and perspectives Loeppky R.N., Michejda C.J. Nitrosamines and related N-nitroso compounds. chemistry and biochemistry:1994;1-18 ACS Symposium Series 553, Washington, DC.
41. Li Z., Li X., Petrović S., Harrison D.J. Dual-sorption model of water uptake in poly(vinyl chloride)-based ion-selective membranes. experimental water concentration and transport parameters Anal Chem. 68:1996;1717-1725.
42. Mowery K.A., Meyerhoff M.E. The transport of nitric oxide through various polymeric matrices. Polymer. 40:1999;6203-6207.
43. Schwake A., Ross B., Cammann K. Basic analysis on the origin of asymmetry potentials observed with ion-selective polymer matrix membranes. Proc Eurosensors XI. 1:1997;243-246.
44. -. O-Functionalization chemistry. J Org Chem. 57:1992;6134-6138.
45. Kusy R.P., Whitley J.Q., Buck R.P., Cosofret V.V., Lindner E. Syntheses and kinetics of piperazine-modified poly(vinyl chloride)s for use as fixed-site proton carrier membranes. Polymer. 35:1994;2141-2147.
46. Yang V.C., Ma S., Meyerhoff M.E. Thinning blood safely. Chemtech. 23:1993;25-32.
47. Monroe J.M., Lijana R.C., Williams M.C. Hemolytic properties of special materials exposed to a shear flow, and plasma changes with shear. Biomater Med Devices Artif Organs. 8:1980;103-144.
48. Davidson G.W.R. III, Peppas N.A., Thornhill J.A., Ash S.R. Assessment of biomaterials as components of a reciprocating dialyser during canine dialysis. Biomaterials. 5:1984;227-233.
49. Fu B., Bakker E., Yang V.C., Meyerhoff M.E. Extraction thermodynamics of polyanions into plasticized polymer membranes doped with lipophilic ion exchangers. a potentiometric study Macromolecules. 28:1995;5834-5840.
50. Radomski M.W., Palmer R.M.J., Moncada S. The role of nitric oxide and cGMP in platelet adhesion to the vascular endothelium. Biochem Biophys Res Commun. 148:1987;1482-1489.
51. Miwa H., Matsuda T. An integrated approach to the design and engineering of hybrid arterial prostheses. J Vasc Surg. 19:1996;658-667.
52. Cholakis C.H., Zingg W., Sefton M.V. Effect of heparin-PVA hydrogel on platelets in a chronic canine arterio-venous shunt. J Biomed Mater Res. 23:1989;417-441.
53. Salzman E.W., Rosenberg R.D., Smith M.H., Lindon J.N., Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest. 65:1980;64-73.
54. Thomson C., Forbes C.D., Prentice C.R.M. The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo. Clin Sci Mol Med. 45:1973;485-494.
55. Llanos G.R., Sefton M.V. Heparin-poly(ethylene glycol)-poly(vinyl alcohol) hydrogel. preparation and assessment of thrombogenicity Biomaterials. 13:1992;421-424.
56. Schoenfisch MH, Mowery KA, Rader M, Meyerhoff ME. Improving the biocompatibility of intravascular amperometric oxygen sensors via nitric oxide release. Abstracts of Papers, 216th ACS National Meeting, Boston, MA, Aug1998; paper ANYL 62.
57. Schoenfisch MH, Mowery KA, Rader MV, Baliga N, Negolo JC, Wahr JA, Politis JK, Meyerhoff ME. Improving the thromboresistivity of intravascular sensors via nitric oxide release. Part I: fabrication and in vivo evaluation of NO releasing amperometric oxygen sensors, in preparation.
58. Annich GM, Meinhardt JP, Mowery KA, Ashton BA, Merz SI, Hirschl, RB, Meyerhoff ME, Bartlett RH. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit Care Med 1999, in press.